Molina Healthcare, Inc. (MOH)
USD 296.59
(1.65%)
USD 296.59
(1.65%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.46 Billion USD | -52.51% |
| 2022 | -1.61 Billion USD | 21.07% |
| 2021 | -2.04 Billion USD | -13.54% |
| 2020 | -1.8 Billion USD | -86.54% |
| 2019 | -966 Million USD | 29.39% |
| 2018 | -1.36 Billion USD | -34.51% |
| 2017 | -1.01 Billion USD | 13.37% |
| 2016 | -1.17 Billion USD | -63.06% |
| 2015 | -720 Million USD | -13.62% |
| 2014 | -633.67 Million USD | -319.56% |
| 2013 | -151.03 Million USD | 71.65% |
| 2012 | -532.83 Million USD | -111.19% |
| 2011 | -252.3 Million USD | 5.58% |
| 2010 | -267.22 Million USD | 6.29% |
| 2009 | -285.14 Million USD | -52.35% |
| 2008 | -187.16 Million USD | 27.75% |
| 2007 | -259.06 Million USD | 27.77% |
| 2006 | -358.65 Million USD | -43.92% |
| 2005 | -249.2 Million USD | -10.18% |
| 2004 | -226.17 Million USD | -59.45% |
| 2003 | -141.85 Million USD | -4334.33% |
| 2002 | 3.35 Million USD | 103.37% |
| 2001 | -99.34 Million USD | -116.99% |
| 2000 | -45.78 Million USD | -418.87% |
| 1999 | -8.82 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -2.13 Billion USD | 13.48% |
| 2024 Q2 | -1.97 Billion USD | 7.56% |
| 2024 Q3 | -2.4 Billion USD | -11.83% |
| 2023 Q3 | -3.18 Billion USD | -26.02% |
| 2023 Q1 | -2.17 Billion USD | -34.55% |
| 2023 FY | -2.46 Billion USD | -52.51% |
| 2023 Q2 | -2.52 Billion USD | -16.38% |
| 2023 Q4 | -2.46 Billion USD | 22.72% |
| 2022 Q3 | -1.85 Billion USD | 3.7% |
| 2022 FY | -1.61 Billion USD | 21.07% |
| 2022 Q1 | -2.41 Billion USD | -17.94% |
| 2022 Q2 | -1.92 Billion USD | 20.39% |
| 2022 Q4 | -1.61 Billion USD | 12.7% |
| 2021 Q1 | -2.08 Billion USD | -15.43% |
| 2021 FY | -2.04 Billion USD | -13.54% |
| 2021 Q4 | -2.04 Billion USD | -1.94% |
| 2021 Q3 | -2 Billion USD | 11.04% |
| 2021 Q2 | -2.25 Billion USD | -8.46% |
| 2020 Q3 | -1.15 Billion USD | 8.32% |
| 2020 Q1 | -514 Million USD | 46.79% |
| 2020 FY | -1.8 Billion USD | -86.54% |
| 2020 Q4 | -1.8 Billion USD | -55.75% |
| 2020 Q2 | -1.26 Billion USD | -145.53% |
| 2019 FY | -966 Million USD | 29.39% |
| 2019 Q4 | -966 Million USD | 18.96% |
| 2019 Q1 | -1.67 Billion USD | -22.15% |
| 2019 Q3 | -1.19 Billion USD | -66.71% |
| 2019 Q2 | -715 Million USD | 57.21% |
| 2018 Q3 | -1.3 Billion USD | 23.06% |
| 2018 FY | -1.36 Billion USD | -34.51% |
| 2018 Q1 | -1.64 Billion USD | -61.95% |
| 2018 Q2 | -1.69 Billion USD | -2.67% |
| 2018 Q4 | -1.36 Billion USD | -5.15% |
| 2017 Q1 | -1.54 Billion USD | -31.52% |
| 2017 FY | -1.01 Billion USD | 13.37% |
| 2017 Q4 | -1.01 Billion USD | 37.87% |
| 2017 Q3 | -1.63 Billion USD | -65.19% |
| 2017 Q2 | -991 Million USD | 35.82% |
| 2016 FY | -1.17 Billion USD | -63.06% |
| 2016 Q1 | -538 Million USD | 25.28% |
| 2016 Q2 | -718 Million USD | -33.46% |
| 2016 Q3 | -1.2 Billion USD | -68.11% |
| 2016 Q4 | -1.17 Billion USD | 2.73% |
| 2015 Q1 | -957.4 Million USD | -51.09% |
| 2015 FY | -720 Million USD | -13.62% |
| 2015 Q3 | -1.23 Billion USD | -13.07% |
| 2015 Q2 | -1.09 Billion USD | -14.26% |
| 2015 Q4 | -720 Million USD | 41.79% |
| 2014 Q2 | -216.63 Million USD | 23.74% |
| 2014 Q3 | -689.78 Million USD | -218.41% |
| 2014 Q4 | -633.67 Million USD | 8.14% |
| 2014 Q1 | -284.07 Million USD | -88.09% |
| 2014 FY | -633.67 Million USD | -319.56% |
| 2013 FY | -151.03 Million USD | 71.65% |
| 2013 Q4 | -151.03 Million USD | -74.86% |
| 2013 Q3 | -86.37 Million USD | -558.93% |
| 2013 Q2 | 18.82 Million USD | 103.58% |
| 2013 Q1 | -526.33 Million USD | 1.22% |
| 2012 Q3 | -453.78 Million USD | 0.62% |
| 2012 Q2 | -456.62 Million USD | -58.3% |
| 2012 Q1 | -288.45 Million USD | -14.33% |
| 2012 FY | -532.83 Million USD | -111.19% |
| 2012 Q4 | -532.83 Million USD | -17.42% |
| 2011 FY | -252.3 Million USD | 5.58% |
| 2011 Q4 | -252.3 Million USD | 14.67% |
| 2011 Q3 | -295.68 Million USD | -10.16% |
| 2011 Q1 | -274.28 Million USD | -2.64% |
| 2011 Q2 | -268.41 Million USD | 2.14% |
| 2010 FY | -267.22 Million USD | 6.29% |
| 2010 Q1 | -252.76 Million USD | 11.36% |
| 2010 Q3 | -238.62 Million USD | -40.95% |
| 2010 Q4 | -267.22 Million USD | -11.99% |
| 2010 Q2 | -169.29 Million USD | 33.02% |
| 2009 Q1 | -223.16 Million USD | -39.65% |
| 2009 Q2 | -261.35 Million USD | -17.11% |
| 2009 FY | -285.14 Million USD | -52.35% |
| 2009 Q3 | -265.86 Million USD | -1.73% |
| 2009 Q4 | -285.14 Million USD | -7.25% |
| 2008 Q4 | -159.79 Million USD | 12.41% |
| 2008 FY | -187.16 Million USD | 27.75% |
| 2008 Q1 | -212.15 Million USD | 18.11% |
| 2008 Q2 | -197.28 Million USD | 7.01% |
| 2008 Q3 | -182.43 Million USD | 7.52% |
| 2007 FY | -259.06 Million USD | 27.77% |
| 2007 Q3 | -427.59 Million USD | 3.15% |
| 2007 Q4 | -259.06 Million USD | 39.41% |
| 2007 Q2 | -441.5 Million USD | -13.22% |
| 2007 Q1 | -389.96 Million USD | -8.73% |
| 2006 FY | -358.65 Million USD | -43.92% |
| 2006 Q3 | -322.08 Million USD | -8.4% |
| 2006 Q2 | -297.11 Million USD | -3.04% |
| 2006 Q1 | -288.34 Million USD | -15.71% |
| 2006 Q4 | -358.65 Million USD | -11.35% |
| 2005 FY | -249.2 Million USD | -10.18% |
| 2005 Q1 | -237.47 Million USD | -4.99% |
| 2005 Q2 | -197.55 Million USD | 16.81% |
| 2005 Q4 | -249.2 Million USD | -12.39% |
| 2005 Q3 | -221.72 Million USD | -12.24% |
| 2004 Q2 | -178.33 Million USD | -4.82% |
| 2004 FY | -226.17 Million USD | -59.45% |
| 2004 Q4 | -226.17 Million USD | -3.09% |
| 2004 Q3 | -219.38 Million USD | -23.02% |
| 2004 Q1 | -170.13 Million USD | -19.94% |
| 2003 Q2 | -125.09 Million USD | -1600.7% |
| 2003 FY | -141.85 Million USD | -4334.33% |
| 2003 Q4 | -141.85 Million USD | 12.01% |
| 2003 Q3 | -161.2 Million USD | -28.86% |
| 2003 Q1 | 8.33 Million USD | 0.0% |
| 2002 FY | 3.35 Million USD | 103.37% |
| 2001 FY | -99.34 Million USD | -116.99% |
| 2000 FY | -45.78 Million USD | -418.87% |
| 1999 FY | -8.82 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Cigna Corporation | 23.65 Billion USD | 110.411% |
| Centene Corporation | 636 Million USD | 487.264% |
| CVS Health Corporation | 71.18 Billion USD | 103.46% |
| Elevance Health Inc. | 18.59 Billion USD | 113.246% |
| Humana Inc. | 7.57 Billion USD | 132.515% |
| Oscar Health, Inc. | -1.57 Billion USD | -56.725% |
| UnitedHealth Group Incorporated | 42 Billion USD | 105.863% |